Recurrent Cervical Cancer
Also known as: Cervical cancer recurrent / Carcinoma uterine cervix recurrent / Cervical carcinoma recurrent / Ca cervix recurrent / Carcinoma uterine cerix recurrent / Cervix uteri cancer recurrent / Cervix carcinoma recurrent / Carcinoma cervix recurrent
| Drug | Drug Name | Drug Description |
|---|---|---|
| DB00112 | Bevacizumab | A monoclonal anti-vascular endothelial growth factor antibody used in combination with antineoplastic agents for the treatment of many types of cancer. |
| DB14707 | Cemiplimab | A programmed death receptor-1 blocking antibody used to treat cutaneous squamous cell carcinoma, basal cell carcinoma, and non-small cell lung cancer. |
| DB09037 | Pembrolizumab | A PD-1 blocking antibody used to treat various types of cancer, including metastatic melanoma, non small-cell lung cancer, cervical cancer, head and neck cancer, and Hodgkin's lymphoma. |
| DB16732 | Tisotumab vedotin | A tissue factor-directed antibody drug conjugate that is used to treat adults with recurrent or metastatic cervical cancer with disease progression on or after chemotherapy. |
| DB00361 | Vinorelbine | A vinca alkaloid used in the treatment of metastatic non-small cell lung carcinoma (NSLC) and in conjunction with other drugs in locally advanced NSCLC. |